Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
Francesco Di Pierro, Giuseppe Derosa, Pamela Maffioli, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2359-2366
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 417
Quercetin and its derivates as antiviral potentials: A comprehensive review
Amalia Di Petrillo, Germano Orrù, Antonella Fais, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 266-278
Open Access | Times Cited: 275
Virus-induced senescence is a driver and therapeutic target in COVID-19
Soyoung Lee, Yong Yu, Jakob Trimpert, et al.
Nature (2021) Vol. 599, Iss. 7884, pp. 283-289
Open Access | Times Cited: 268
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Francesco Di Pierro, Somia Iqtadar, Amjad Khan, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2807-2816
Open Access | Times Cited: 150
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 126
COVID-19 and cellular senescence
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 101
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
Konstantinos Evangelou, Dimitris Veroutis, Koralia Paschalaki, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 2, pp. 2102951-2102951
Open Access | Times Cited: 70
Potential pharmacological effect of Quercetin Phytosome™ in the management of hyperuricemia: results from real-life clinical studies
Francesco Di Pierro, Fazle Rabbani, Muhammad Burhan Khan Tareen, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access | Times Cited: 1
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
Mojtaba Shohan, Roohangiz Nashibi, Mohammad‐Reza Mahmoudian‐Sani, et al.
European Journal of Pharmacology (2021) Vol. 914, pp. 174615-174615
Open Access | Times Cited: 86
The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature
Mohd Imran, Hamdy Khamees Thabet, Saleh I. Alaqel, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 876-876
Open Access | Times Cited: 62
Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
Seodhna M. Lynch, Guangran Guo, David S. Gibson, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3367-3367
Open Access | Times Cited: 60
Water as Green Solvent: Methods of Solubilisation and Extraction of Natural Products—Past, Present and Future Solutions
Léo Lajoie, Anne‐Sylvie Fabiano‐Tixier, Farid Chemat
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1507-1507
Open Access | Times Cited: 56
Smart Multifunctional UiO-66 Metal–Organic Framework Nanoparticles with Outstanding Drug-Loading/Release Potential for the Targeted Delivery of Quercetin
Mozhgan Parsaei, Kamran Akhbari
Inorganic Chemistry (2022) Vol. 61, Iss. 37, pp. 14528-14543
Closed Access | Times Cited: 43
Honey and Nigella sativa against COVID‐19 in Pakistan (HNS‐COVID‐PK): A multicenter placebo‐controlled randomized clinical trial
Sohaib Ashraf, Shoaib Ashraf, Moneeb Ashraf, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 2, pp. 627-644
Closed Access | Times Cited: 41
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Quercetin: A Functional Food-Flavonoid Incredibly Attenuates Emerging and Re-Emerging Viral Infections through Immunomodulatory Actions
Fauzia Mahanaz Shorobi, Fatema Yasmin Nisa, Srabonti Saha, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 938-938
Open Access | Times Cited: 36
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
Francesco Di Pierro, Amjad Khan, Somia Iqtadar, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 32
Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters
Lou Delval, Aline Hantute-Ghesquier, Valentin Sencio, et al.
Nature Aging (2023) Vol. 3, Iss. 7, pp. 829-845
Open Access | Times Cited: 25
Inflammation, Mitochondria and Natural Compounds Together in the Circle of Trust
Salvatore Nesci, Anna Spagnoletta, Francesca Oppedisano
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6106-6106
Open Access | Times Cited: 24
Quercetin for the treatment of COVID‐19 patients: A systematic review and meta‐analysis
Huzaifa Ahmad Cheema, Aruba Sohail, Areej Fatima, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Closed Access | Times Cited: 23
Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives
Katharine A. Seton, José Espejo, Karen Giménez-Orenga, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 8
Promising Effects of 3-Month Period of Quercetin Phytosome® Supplementation in the Prevention of Symptomatic COVID-19 Disease in Healthcare Workers: A Pilot Study
Mariangela Rondanelli, Simone Perna, Clara Gasparri, et al.
Life (2022) Vol. 12, Iss. 1, pp. 66-66
Open Access | Times Cited: 34
Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease
Yongli Lyu, Haifeng Zhou, Jia Yang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 34
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 34
A Comprehensive Update on the Bioactive Compounds from Seagrasses
Christina Mutiara Putri Gono, Peni Ahmadi, Triana Hertiani, et al.
Marine Drugs (2022) Vol. 20, Iss. 7, pp. 406-406
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top